Aeras CEO Jim Connolly to step down

Aeras announced that Jim Connolly will step down as CEO effective January 31, 2013 but remain active on its Board of Directors. Aeras Chief Scientific Officer Dr. Tom Evans will serve as interim CEO, starting on February 1, 2013, while the Board of Directors selects a permanent successor. Aeras describes itself as “a non-profit product development organization dedicated to the development of effective tuberculosis (TB) vaccines and biologics to prevent TB across all age groups in an affordable and sustainable manner.”